Assignee
ABBVIE SARL
LU·10 granted patents·7 pending applications·109 citations·filing 2016–2019
Top patents by PatentIndex Score
17 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0394US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0486US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 0584US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 0684US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 0782US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0878US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 0976US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 1063US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 1159US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 1257US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 1355US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 1454US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 1553US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 1640US2020123137A1Deuterated cftr modulators and methods of useABBVIE SARL·Filed 2017·Application pending·0 cites
- 1735US10130622B2Compounds for treatment of cystic fibrosisABBVIE SARL·Filed 2016·Granted Nov 20, 2018·0 cites·33 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →